Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
06/2007
06/20/2007EP1797096A2 Novel pyrazolopyrimidines
06/20/2007EP1797095A1 6-phenyl-7-amino-triazolopyrimidines, methods for the production thereof, the use thereof for controlling pathogenic fungi, and agents containing the same
06/20/2007EP1797094A2 1,3-disubstituted heteroaryl nmda/nr2b antagonists
06/20/2007EP1797084A1 NOVEL HETEROCYCLIC NF-kB INHIBITORS
06/20/2007EP1797065A2 Acyclic 1,3-diamines and uses therefor
06/20/2007EP1797054A2 Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds
06/20/2007EP1796671A1 Amorphous form of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
06/20/2007EP1796669A2 Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
06/20/2007EP1796664A1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
06/20/2007EP1796467A2 Imidazo{4,5-b}pyrazinone inhibitors of protein kinases
06/20/2007EP1355913B1 Paramagnetic metal-phthalocyanine complex compounds and contrast agent using the same
06/20/2007CN1984917A HIV integrase inhibitors: cyclic pyrimidinone compounds
06/20/2007CN1984915A Adduct of fluorescent dye and tumor avid tetrapyrrole
06/20/2007CN1984914A Amide derivatives of 7-amino-3-phenyl-dihydropyrimido [4,5-d]pyrimidinones, their manufacture and use as protein kinase ingibitor
06/20/2007CN1984911A 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha7-NACHR ligands for the treatment of CNS diseases
06/20/2007CN1984907A Novel heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
06/20/2007CN1984660A 4-arylamino-quinazolines as activators of aspartic acid specificity cysteine protease and inducers of apoptosis
06/20/2007CN1982312A Method for purification of indole derivative trimer, electrode active substance and electrochemical cell
06/20/2007CN1321996C Process for preparing 2-iminopyrrolidine derivatives
06/19/2007US7232901 For preparing 2,4-disubstituted pyrrolotriazine compounds
06/19/2007US7232842 Kinase inhibitors and associated pharmaceutical compositions and methods of use
06/19/2007US7232827 Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one derivatives
06/19/2007US7232824 Used for treating disorders with enhanced activity of transforming growth factor beta TGF- beta, kidney disorders associated with unregulated TGF- beta activity and excessive fibrosis including glomerulonephritis (GN), mesangial proliferative GN, immune GN, and crescentic GN
06/19/2007US7232823 such as 1-[2-(2-chloro-phenyl)-3-(4-fluoro-phenyl)-2H-pyrazolo[3,4-d]pyridazin-7-yl]-4-isopropylamino-piperidine-4-carboxylic acid amide; for treatment of eating disorders and psychological disorders
06/19/2007US7232822 E.g., perhydrotriazino[1,2-a]piperazinediones, used for drug screening, diagnoses and treating disorders modulated by Wnt-signaling pathway, such as cancer, restenosis associated with angioplasty, polycystic kidney disease, aberrant angiogenesis disease, rheumatoid arthritis, tuberous sclerosis complex
06/19/2007US7232819 Dihydroxypyrimidine carboxamide inhibitors of HIV integrase
06/19/2007US7232816 Phosphodiesterase inhibitors; used to treat inflammatory conditions, allergies such as rhinitis, respiratory system disorders and cancer
06/19/2007US7232814 Heterocyclic carboxy amines such as 9-nitro-7,12-dihydroindolo (3,2-d)(1)-benzazepin-6(5H)-one, used as inhibitors of glycogen synthase kinase-3 beta or cyclin dependent kinases
06/14/2007WO2007067781A2 9-membered heterobicyclic compounds as inhibitors of protein kinases
06/14/2007WO2007067709A1 Process to prepare substituted imidazopyrazine compounds
06/14/2007WO2007067629A1 Bradykinin 1 receptor antagonists
06/14/2007WO2007066200A2 Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
06/14/2007WO2007065820A1 Tricyclic amide derivatives useful for treating obesity
06/14/2007WO2007065663A1 Quinazolinone derivatives as vanilloid antagonists
06/14/2007WO2007050721A3 Heterocyclic aspartyl protease inhibitors
06/14/2007WO2007044407A3 Pyrazolo (1 , 5a) pyrimidines as protein kinase inhibitors
06/14/2007WO2007030582A3 Acyclic ikur inhibitors
06/14/2007US20070135654 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING alpha-AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME
06/14/2007US20070135646 Photoconductive members
06/14/2007US20070135637 Pentasil-structuer zeolithic material the production and use thereof
06/14/2007US20070135628 Crystalline lestaurtinib hydrates and crystalline lestaurtinib hemihydrate hemiacetonitrileate and crystalline lestaurtinib hemihydrate hemitetrahydrofuranate
06/14/2007US20070135484 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor
06/14/2007US20070135461 3-Cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile; immune-related diseases, skin disorders, myeloid proliferative disorders, cancer
06/14/2007US20070135460 7H-pyrrolopyrimidine derivatives
06/14/2007US20070135459 Substituted 7-aza-quinazoline compounds useful as p38 kinase inhibitors
06/14/2007US20070135458 6-Substituted pyrido-pyrimidines
06/14/2007US20070135457 Pyrido[2,3-d]pyrimidine-2,4-diamines as pde2 inhibitors
06/14/2007US20070135454 Bicyclic pyrimidin-4(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1-receptor(vr1)
06/14/2007US20070135453 6-(2,4,6-Trihalophenyl)triazolopyrimidines, their preparation and their use for controlling harmful fungi, and compositions comprising these compounds
06/14/2007US20070135452 Nitrogen-containing fused heterocyclic compounds
06/14/2007US20070135443 Novel tyrosine kinase inhibitors
06/14/2007US20070135439 Novel inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
06/14/2007US20070135417 1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles,and chromones and preparation and uses thereof
06/14/2007US20070135416 Tricyclic amide derivatives
06/14/2007US20070135415 Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy
06/14/2007US20070135405 Novel diazabicyclononene and tetrahydropyridine derivatives with a new polar side-chain
06/14/2007US20070135401 Lestaurtinib Crystalline Form 1, crystalline lestaurimib anhydrate and amorphous lestaurimib
06/14/2007US20070135387 Inhibitors of protein kinases
06/14/2007US20070134729 Novel antibacterial agents
06/14/2007US20070134572 Photoconductive members
06/14/2007US20070134161 Methods of determining beta-iii tubulin expression
06/14/2007US20070134150 Method of fullerene separation and complex containing fullerene
06/14/2007CA2783572A1 Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
06/14/2007CA2632635A1 Novel inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
06/14/2007CA2631128A1 Tricyclic amide derivatives useful for treating obesity
06/14/2007CA2631037A1 Bradykinin 1 receptor antagonists
06/14/2007CA2630417A1 Quinazolinone derivatives as vanilloid antagonists
06/13/2007EP1794164A2 Bridged piperazine and piperidine derivatives as ccr1 antagonists
06/13/2007EP1794163A1 Method of preparing poly(adp-ribose) polymerases inhibitors
06/13/2007EP1794161A2 Muscarinic receptor antagonists
06/13/2007EP1794137A2 Specific kinase inhibitors
06/13/2007EP1793828A2 Fibrate compounds having ppar agonist activity
06/13/2007EP1793822A1 Tricycles, their manufacture and use as pharmaceutical agents
06/13/2007EP1534709B1 Pyrazolopyrimidines as cyclin dependent kinase inhibitors
06/13/2007EP1490065B1 Benzylimidazolyl substituted 2-quinolinone and quinazolinone derivatives for use as farnesyl transferase inhibitors
06/13/2007EP1320383B1 Photosensitisers
06/13/2007EP1083177B1 Compounds capable of cleaving double-stranded dna and method of utilization of the same
06/13/2007EP1032574B1 INDOLO 2,1-b|QUINAZOLE-6,12-DIONE ANTIMALARIAL COMPOUNDS AND METHODS OF TREATING MALARIA THEREWITH
06/13/2007EP1000040B1 Il-5 inhibiting 6-azauracil derivatives
06/13/2007CN1981384A Materials for photoelectric conversion devices and photoelectric conversion devices
06/13/2007CN1980935A Substituted 6-phenyl-7-amino-triazolopyrimidines, method for the production thereof, their use for controlling pathogenic fungi, and agents containing these compounds
06/13/2007CN1980934A Novel indole derivatives as selective androgen receptor modulators (sarms)
06/13/2007CN1980933A Amide derivatives of 3-phenyl dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents
06/13/2007CN1980932A Use of 6-(2-tolyl)-triazolopyrimidines as fungicides, novel 6-(2-tolyl)-triazolopyrimidines, method for the production thereof, use thereof for controlling harmful fungi, and agents containing the sam
06/13/2007CN1980931A Compounds with atypical antipsychotic activity.
06/13/2007CN1980926A Azinyl imidazoazine and azinyl carboxamide
06/13/2007CN1980710A Substituted azepine derivatives as serotonin receptor modulators
06/13/2007CN1980661A Cationic bacteriochlorophyll derivatives and uses thereof
06/13/2007CN1978439A Star-shaped oligothiophene-arylene derivatives and organic thin film transistors using the same
06/12/2007US7230104 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines
06/12/2007US7230103 Substituted 3,4-dihydropyrido[1,2-a]pyrimidines
06/12/2007US7230088 Compounds for dual photodiagnosis and therapy
06/12/2007US7230071 Methods for polymerization of electronic and photonic polymers
06/12/2007US7230026 Selected fused pyrrolocarbazoles
06/12/2007US7230024 such as 2-(2-chloro-phenyl)-5-isopropyl-3-(3,4,5-trifluoro-phenyl)-4,5-dihydro-2H-pyrrolo[3,4-c]pyrazol-6-one; for treatment of eating disorders and psychological disorders
06/12/2007US7230011 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5ht6 receptor
06/12/2007US7229990 E.g., tert-Butyl-5-amino-2-methylthio-4-(3-methoxyphenyl)-quinazoline-6 -carboxamide; used in fertility regulation therapies.
06/12/2007US7229985 2-(1-isopropoxy-carbonyloxy-2-methylpropyl)-7, 8-dimethoxy-4(5H), 10-dioxo-2H-1,2,3-triazolo[4,5-c][1]benzazepine having a solubility of 15-20 mu g/mL in a 1 wt % methylcellulose solution at 37 degrees and a polymer, especially methylcellulose and/or hydroxypropylmethylcellulose.
06/12/2007US7229983 antibacterial; beta -lactam antibiotics
06/12/2007CA2417264C Crystalline therapeutic agent
1 ... 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 ... 573